Introduction
issolution is an area where there is little a labo rato ry can do to truly improve t u rn -a round time.The specified dissolution time is the time of the actual dissolution run and we are tied to that time. Ma n u a l l y pe rfo rmed dissolution testing is generally ve ry d e pe n d e nt on analyst assistance and invo l ve m e nt . Even on short ru n s, the analyst must fill the ve s s e l s, m e a s u re the te m pe rat u re of the media, d rop the tablets or ca p s u l e s, pull aliquots of sample solution for test at specified times, and at the end of the a n a l ys i s, d i s ca rd the used media and clean the ve ssels for the next ru n .
Most laboratories have increased efficiencies by using automated media heaters,degassers,and/or dispensers.They have also utilized different types of automated samplers or automated samplers equipped with a detection device (flow-through spectrophotometers) to increase efficiency and decrease analyst involvement.Several companies have developed automated dissolution systems. The advantage of these systems can be realized in several ways.First,the automated cleaning of the bath vessels can eliminate costly analyst time and vessel breakage (safety).It also provides a more consistent cleaning technique.Second, except for initial run setup,the overall automation testing can be performed without an analyst being present.This allows the analyst to perform other tasks in the lab while the system is running.Or,the system can be run on 'off shifts'(night) or when minimum lab crews are available.Also,automated systems have capabilities to drop the tablets or capsules, record the media temperature prior to and after the test, degas and dispense the media, sample the vessels at pre-programmed times, filter the sample solutions,and perform some limited analysis on those sample solutions. Some of the systems available today can also perform several different dissolution tests in a single series of runs. For example,different products or formulations requiring different media or different sampling times can be tested within the same run series.
The main objective for utilizing automated dissolution for our laboratory was to incorporate these time saving advantages.The transfer of a relatively short run-time,currently validated dissolution method from either a semi-automated or manual technique to a Zymark ® MultiDose® Dissolution System was deemed the most efficient course to take.
The selected prod u ct for tra n s fer was a 60-mg powder-filled capsule (hard gelat i n ) .The dissolution method utilizes a USP ty pe 2 apparatus with a ro t ation of 50 rp m ,the media is 900-mL of deioni zed water at 37 ± 0.5 °C.The sample times are spe cified at 15 and 45 minute s.
Ex pe ri m e nt a l

Fi l ter St u dy
Fi l ter co m p a rison studies we re nece s s a ry due to a p ro posed change to the curre nt approved methodo l ogy.The curre nt auto-sampler method utilized 45-µm po l ye t hylene sample-pro be-tip filte r s.Th e a u to m ated sys tem inco rpo rates ca rousel heads, which are mounted on top of each ve s s e l .The heads include sampling lines,t h e rm i s to r s,media tra n s fe r l i n e s,and tablet/capsule holding ce l l s.This gre at l y re s t ri cts access to the sample pro bes for filte r c h a n g e s.The changing of pro be filters would also re q u i re analyst invo l ve m e nt be tween individual ru n s.To maintain the filte ring ste p,the auto m ate d s ys tem we selected for use,u t i l i zes a filter stat i o n , which dispenses 25-µm syringe ty pe filte r s.
The initial filter study inve s t i g ated for po s s i b l e a b s o rption of the act i ve ingre d i e nt by the filte r m e d i a .Studies we re co n d u cted using a re fe re n ce s t a n d a rd solution and manually filte ring it thro u g h d i f fe re nt media filte r s.A ten-mL syri n g e,f i t ted with a filte r,was filled with the re fe re n ce standard solut i o n .Six HPLC sample vials we re sequentially filled with approx i m ately 1.5 mL of solution.The same p roce d u re was co n d u cted for each re s pe ct i ve filte r ty pe.Each set of filte red solutions was analyze d against the unfilte red re fe re n ce standard.Th e results for the filter inve s t i g ation are pre s e nted in 1.0-µm glass fiber filters we re selected for furt h e r i nve s t i g ation due to the lower backp re s s u re observe d and acceptable results obtained for Fexo fenadine HCl . Stock sample solutions from three diffe re nt lots of p rod u ct we re filte red through the curre nt po l ye t hylene filters for HPLC analys i s.The same stock sample solutions we re filte red through the pro posed glass f i ber filters for further analys i s.The samples we re a n a l y zed on the same HPLC sys tem for a dire ct co m p a rison of the Fexo fenadine HCl re s u l t s.Th e results of the study indicate that there was no significa nt diffe re n ce for Fexo fenadine HCl using either ty pe of filte r.The results are pre s e nted in Table 2 (page 13).
Flush Volume Study
A flush volume study was pe rfo rmed to dete rm i n e the minimum volume re q u i red to thoroughly flush the Mu l t i Dose® sys tem sample lines be tween each set of sample test solutions (diffe re nt time po i nts) for the same dissolution ru n .Th e re are seve ral vo l u m e options to choose from in the auto m ated sys tem softwa re.The study eva l u ated each volume option to m i n i m i ze the chance of cro s s -co nt a m i n ation with the p revious time-po i nt sample.The 12-mL volume option was selected to ensure adequate flushing of the sample lines.This option extends beyond the acce p table results achieved with a 10-mL flush and beyo n d the lowest flush setting,also 10-mL.The flush vo l u m e s t u dy results are pre s e nted in Table 3 .
Sample Carryover (Run to Run)
A study was co n d u cted to eva l u ate sample ca rryove r f rom previous ru n s.This study helped dete rmine the n u m ber of wash cycles at the end of a run to assure p ro per washing and rinsing of the vessels and sample lines prior to the next dissolution ru n .The auto m ate d s ys tem was set up for eight separate ru n s.Four of the e i g ht runs we re pe rfo rmed using prod u ct samples ( capsules) while each run fo l l owing a capsule ru n was pe rfo rmed using only media (wate r ) .Fo r ex a m p l e,the first run was pe rfo rmed using a set of six ca p s u l e s.For the next ru n ,the ca p s u l e / t a b l e t d i s penser did not dispense any samples into the vessels so the run was pe rfo rmed as a media blank to monitor Fexo fenadine HCl ca rryover from the p revious ru n .The number of hot water wash cyc l e s was sequentially increased from one to four for each set (capsule run/media blank run) of dissolution runs to dete rmine the number of washes re q u i re d to adequately clean the vessels and lines to elimin ate sample ca rryover to the next ru n .
The water blank samples fo l l owing each ca p s u l e run we re analyzed for residual Fexo fenadine HCl by H P LC .The dete cted levels of Fexo fenadine HCl fro m this study we re significa ntly less than the va l i d ate d range of quant i t ation and be l ow the va l i d ate d linear ra n g e,t h e re fo re the ca rryover results are only e s t i m at i o n s.The results for the water blank samples for the 15-minute time po i nt indicate less than an e s t i m ated 0.05 % of label claim (60 mg Capsules) of residual of Fexo fenadine HCl remaining after each of the four levels of hot water wash cyc l e s.Th e results for the 45-minute time po i nt we re not more than an estimated 0.02 % of label claim re s i d u a l Fexo fenadine HCl for each of the hot water wa s h cyc l e s.The results indicate adequate washing and rinsing at one wash but the pro posed auto m ate d m e t h od specifies two wash cycles prior to the start of the next ru n .This ensures adequate washing and rinsing of the vessels and lines and also exte n d s beyond the minimum limit (1) of washes for the s ys te m .The results for the ca rryover study are p re s e nted in A study was co n d u cted to eva l u ate the eva po rat i o n s t a b i l i ty of the sample solutions in split-septa ca p ped HPLC vials from one to four days on the sample dispe n s i n g s t at i o n .This would allow HPLC analysis of samples on Mo n d ay from dissolution runs pe rfo rmed on Fri d ay.In ord e r to mimic actual dissolution te s t s,f i ve sets of six,6 0 -m g Fexo fenadine HCl capsules from one sample lot we re te s te d using the auto m ated sys tem with the specified para m e te r s in the pro posed auto m ated method.A single sample set of 6 capsules was te s ted for each stability eva l u ation time po i nt .For ex a m p l e,all five sets of samples we re te s te d co n s e c u t i vely on the same day,with sample solutions Table 4 : Sample Carryover Study Results for Fexofenadine HCl d rawn at the specified 15 and 45-minute inte rva l s.Th e samples we re sto re d,u n d i s t u r be d,in split-septa ca p ped HPLC vials on the sample dispensing station at ambient labo rato ry co n d i t i o n s.Sample set number one was re m oved from the d i s pensing station and analyzed by HPLC the same day the samples we re drawn (Day 0 or Initial).Sample set number two was re m oved and analyzed by HPLC the next day (Day 1), sample set three was re m oved and analyzed by HPLC the fo l l owing day (Day 2),and so on for samples for Day 3 and 4. The results pre s e nted in Table 5 i n d i cate that the sample solutions are stable from eva po ration in the split-septa ca p pe d vials for up to four days.
Equivalency Study
Th ree separate lots of prod u ct we re te s ted at n=12 ove r two separate days (n=24 for each lot).The sampling from the vessels was pe rfo rmed simultaneously using two diffe re nt sampling dev i ce s.One sampling dev i ce was the curre nt l y a p p roved auto -s a m p l e r,while the other dev i ce was the p ro posed auto m ated dissolution sys te m .The sample solu- 
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Results
The co m p a rison study results we re eva l u ated using s eve ral stat i s t i cal te c h n i q u e s.The data was eva l u ated using single factor An a l ysis of Va ri a n ce (ANOVA ,single factor) and the results indicate that the methods are equiva l e nt .
The ANOVA results we re significa ntly lower than the a l l owed cri t i cal value for equiva l e n ce.The results for the A N O VA results are pre s e nted in The data was again eva l u ated using the stat i s t i ca l fo rmulas pre s e nted by the Food and Drug Ad m i n i s t rat i o n for Dissolution Testing of Immediate Release Solid Ora l Dosage Fo rms (Gu i d a n ce for Industry ( 1 ) ,Au g u s t,1 9 9 7 ) .Th i s s t at i s t i cal eva l u ation of the data co m p a res the results from a c u rre ntly approved technique or method to those obtained using a pro po s e d,new technique or method.The ave ra g e Where: n = number of time points. Rt = the mean dissolution value of the reference run (current system results) at time t. Tt = the mean dissolution value of the test run (automated system results) at time t. t h ree te s ted lots.The results are higher than the t-test (95% co n f i d e n ce) cri t i cal limit and indicate that they may not be e q u i va l e nt .The results are pre s e nted in Table 8 .
Note: For similarity; f1 value should be close to 0 (0 -15) f2 value should be close to 100 (50-100)
Difference Factor (f1) Similarity Factor (f2) d ata from each time po i nt for each technique is co m p a re d and the ove rall diffe re n ce (Di f fe re n ce Fa cto r,f1) and simil a ri ty (Si m i l a ri ty Fa cto r,f2) of the two curves is ca l c u l ate d.Fo r the curves to be similar,the f1 factor should be close to 0 (0-15) and the f2 factor should be close to 100 (50-100). The fo rmulas for the f1 and f2 factors are displayed in Ta b l e 9 .
The results obtained using the Di f fe re n ce and Si m i l a ri ty Fa ctors indicate that the two dissolution te c h n i q u e s ( c u rves) are similar,thus the pro posed auto m ated method p rod u ces results that are similar to those obtained using the c u rre nt method.The stat i s t i cal results for the f1 and f2 f a ctors are pre s e nted in Table 10 . 
